Houston-based Quidnet Energy has closed a $10 million series B round and secured a big contract with the state of New York. Getty Images

Houston-based renewable energy company that focuses on clean energy storage closed its $10 million series B financing round and secured a major contract.

Quidnet Energy announced its latest round and the execution of a contract with the New York State Energy Development Authority. Bill Gates-backed Breakthrough Energy Ventures and Canada-based Evok Innovations, which both previously invested in the company, contributed to the round. The round also featured new investors Trafigura and The Jeremy and Hannelore Grantham Environmental Trust.

"Long-duration electricity storage is critical to the energy transition. It's exciting to see how Quidnet is bringing this viable long-duration solution to the market," says Mike Biddle, managing director at Evok Innovations, in a news release. "Because they are leveraging long understood geologic principles, we are confident that they can scale rapidly. We are pleased to support the Quidnet team through its next phase of commercial growth."

According to the release, the company will use the funds to grow its team and scale up its operations in order to be able to deliver commercial-scale projects across the country's electric grid.

"Integrating renewables and replacing retiring thermal generation require cost-effective long-duration electricity storage at an immense scale," says Quidnet Energy CEO Joe Zhou in the release. "While traditional pumped hydro has provided over 95 percent of the world's grid-scale storage, that approach faces significant siting and cost limitations going forward. Quidnet unlocks these constraints to fundamentally change the economics and deployment profile of long-duration storage."

Quidnet's deal with NYSEDA is a part of the organization's efforts to reduce the state's carbon footprint while also lowering the cost of traditional energy storage.

"Under Governor Cuomo's leadership, New York is investing in the technology research and development needed to advance a 21st electric grid that can support the State's growing influx of renewable energy," says Alicia Barton, president and CEO of NYSERDA, in the release. "Congratulations to Quidnet on this opportunity to develop and demonstrate the value that this innovative technology can bring to New York as we work to reduce greenhouse gas emissions and transition to a 100 percent clean electric grid."

Last month, the Rice Alliance for Technology and Entrepreneurship hosted its annual Energy Tech Venture Day online, and Quidnet was among the Houston energy companies to pitch virtually.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.